Skip to content 
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates. Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics, including novel combinations. The company is headquartered in Waltham, Massachusetts. more
| Time Frame | CBIO | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 5.31% | 1.07% | 0.74% |
| 1-Month Return | -30.47% | 1.46% | 1.28% |
| 3-Month Return | -25.4% | 3.51% | 3.6% |
| 6-Month Return | -28.53% | 15.29% | 7.31% |
| 1-Year Return | -68.65% | 7.7% | 11.97% |
| 3-Year Return | -94.94% | 21.02% | 72.07% |
| 5-Year Return | -97.48% | 37.81% | 76.01% |
| 10-Year Return | -98.14% | 139.15% | 258.47% |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| CBIO | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| CBIO | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Crescent Biopharma, Inc. (CBIO) share price today is $11.74
Yes, Indians can buy shares of Crescent Biopharma, Inc. (CBIO) on Vested. To buy
Yes, you can purchase fractional shares of Crescent Biopharma, Inc. (CBIO) via the Vested app. You can start investing in Crescent Biopharma, Inc. (CBIO) with a minimum investment of $1.
You can invest in shares of Crescent Biopharma, Inc. (CBIO) via Vested in three simple steps:
The 52-week high price of Crescent Biopharma, Inc. (CBIO) is $31. The 52-week low price of Crescent Biopharma, Inc. (CBIO) is $8.72.
The price-to-earnings (P/E) ratio of Crescent Biopharma, Inc. (CBIO) is
The price-to-book (P/B) ratio of Crescent Biopharma, Inc. (CBIO) is 0.00
The dividend yield of Crescent Biopharma, Inc. (CBIO) is 0.00%
The market capitalization of Crescent Biopharma, Inc. (CBIO) is $295.94M
The stock symbol (or ticker) of Crescent Biopharma, Inc. is CBIO
Consider the share price of Crescent Biopharma, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Crescent Biopharma, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Crescent Biopharma, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Crescent Biopharma, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Crescent Biopharma, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Crescent Biopharma, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
